12 results on '"Bernedo, V."'
Search Results
2. Prevalencia de esofagitis eosinofílica: estudio multicéntrico en población pediátrica evaluada en 36 centros de gastroenterología de América Latina
- Author
-
Pierre, R., Vieira, M., Vázquez, R., Ninomiya, I., Messere, G., Daza, W., Dadan, S., Higuera, M., Sifontes, L., Harris, P., Gana, J.C., Rodríguez, M., Vasquez, M., González, M., Rivera, J., Gonzales, J., Angulo, D., Cetraro, M.D., Del Compare, M., López, K., Navarro, D., Calva, R., Wagener, M., Zablah, R., Carias, A., Calderón, O., Vera-Chamorro, J.F., Toca, M.C., Dewaele, M.R., Iglesias, C., Delgado, L., León, K., Hassan, I., Ussher, F., Follett, F., Bernedo, V., Grinblat, V., Agüero, N., Oviedo, C., García, A.G., Salazar, A., Coello, P., Furnes, R., Menchaca, M., Fernández, M., Khoury, A., Rojo, C., Fernández, S., and Morao, C.
- Published
- 2019
- Full Text
- View/download PDF
3. Quality of life post-reconstruction of the bile tract
- Author
-
Losada, H., Troncoso, A., Sanhueza, F., Silva, J., Palma, M., Vera, R., Bernedo, V., and Godoy, B.
- Published
- 2021
- Full Text
- View/download PDF
4. Laparoscopic cystectomy in hydathidic liver cyst. Case series
- Author
-
Losada, H., Troncoso, A., Sanhueza, F., Rozas, M., Bernedo, V., Godoy, B., Vera, R., and Flandez, R.
- Published
- 2021
- Full Text
- View/download PDF
5. Food-sensitized pediatric patients show colonic cow's milk protein-specific Th2 cells.
- Author
-
Canziani KE, Ruiz MC, Candia MR, Ilid M, Feregotti E, Curciarello R, Álvarez MC, Guzmán L, Bernedo V, García M, Bohle B, Docena GH, and Muglia CI
- Subjects
- Animals, Female, Child, Humans, Cattle, Infant, Th2 Cells metabolism, Interleukin-4, Interleukin-13 metabolism, Allergens, Milk Proteins, Colon, Immunoglobulin E, Milk Hypersensitivity, Food Hypersensitivity
- Abstract
Food allergies have become a health concern worldwide. Around 6% to 10% of children are allergic to cow's milk proteins. We have previously characterized colorectal polyps in patients sensitized to food allergens. These polyps are classified as inflammatory and present a type 2 environment, with elevated interleukin (IL)-13 and IL-4, and are a site of immunoglobulin E synthesis. In this study, we characterized and isolated cow's milk protein-specific T cell lines and T cell clones from the lamina propria of polyps from patients sensitized to these proteins. Isolated T cells responded to cow's milk proteins similarly to peripheral blood T cells, showing antigen-specific cell proliferation and Th2 cytokines release in vitro. T cell clones obtained were all CD4+ T cells and expressed the membrane TCRαβ receptor and secreted higher IL-4, IL-5, and IL-13 amounts than unstimulated cells, whereas interferon γ secretion remained unchanged. Remarkably, the gut homing chemokine receptor CCR9 was augmented in cow's milk-specific peripheral and lamina propria T cells, and CCL25 was found to be expressed in the inflammatory polyp tissue and not in the adjacent mucosa. In conclusion, we isolated and characterized cow's milk-specific lamina propria CD4+ Th2 cells from colonic inflammatory polyps. CCR9 expression on these cells, along with increase secretion of CCL25 in the polyp, favors recruitment and cow's milk-specific allergic response within the inflammatory polyp tissue. Our findings may be critical to understand the underlying mechanism that promotes immunoglobulin E synthesis in the colon of cow's milk proteins allergic patients, contributing to the development of novel T cell-targeted immunotherapies., Competing Interests: Conflict of interest statement. The authors declare no conflicts of interest., (© The Author(s) 2023. Published by Oxford University Press on behalf of Society for Leukocyte Biology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
6. Type-2 Cytokines Promote the Secretion of the Eosinophil-Attractant CCL26 by Intestinal Epithelial Cells in Food-Sensitized Patients.
- Author
-
Vaccaro J, Canziani KE, Guzmán L, Bernedo V, García M, Altamirano EM, Feregotti E, Curciarello R, Muglia CI, and Docena GH
- Subjects
- Caco-2 Cells, Chemokine CCL26, Chemokines, CC metabolism, Child, Cytokines metabolism, Eosinophils metabolism, Epithelial Cells metabolism, Humans, Colonic Polyps, Interleukin-13 metabolism
- Abstract
Several inflammatory processes of the bowel are characterized by an accumulation of eosinophils at inflammation sites. The mechanisms that govern mucosal infiltration with eosinophils are not fully understood. In this work, we studied the colorectal polyp-confined tissue containing eosinophils and we hypothesized that intestinal epithelial cells are the cell source of eotaxin-3 or CCL26, a potent chemoattractant for eosinophils. We analyzed colorectal polyps (n=50) from pediatric patients with rectal bleeding by H&E staining and eosin staining, and different pro-inflammatory cytokines were assessed by RT-qPCR and ELISA. IgE and CCL26 were investigated by RT-qPCR, ELISA and confocal microscopy. Finally, the intracellular signaling pathway that mediates the CCL26 production was analyzed using a kinase array and immunoblotting in human intestinal Caco-2 cell line. We found a dense cell agglomeration within the polyps, with a significantly higher frequency of eosinophils than in control adjacent tissue. IL-4 and IL-13 were significantly up-regulated in polyps and CCL26 was elevated in the epithelial compartment. Experiments with Caco-2 cells showed that the type-2 cytokine IL-13 increased STAT3 and STAT6 phosphorylation and eotaxin-3 secretion. The addition of the blocking antibody Dupilumab or the inhibitor Ruxolitinib to the cytokine-stimulated Caco-2 cells diminished the CCL26 secretion to basal levels in a dose-dependent manner. In conclusion, our findings demonstrate a high frequency of eosinophils, and elevated levels of type-2 cytokines and eotaxin-3 in the inflammatory stroma of colorectal polyps from pediatric patients. Polyp epithelial cells showed to be the main cell source of CCL26, and IL-13 was the main trigger of this chemokine through the activation of the STAT3/STAT6/JAK1-2 pathway. We suggest that the epithelial compartment actively participates in the recruitment of eosinophils to the colonic polyp-confined inflammatory environment., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Vaccaro, Canziani, Guzmán, Bernedo, García, Altamirano, Feregotti, Curciarello, Muglia and Docena.)
- Published
- 2022
- Full Text
- View/download PDF
7. Direct evidence for local IgE production in the human colonic mucosa.
- Author
-
Canziani KE, Pucci Molineris M, Guzman L, Bernedo V, García M, Altamirano EM, Muglia CI, and Docena GH
- Subjects
- Allergens, Humans, Intestinal Mucosa, Food Hypersensitivity, Immunoglobulin E
- Published
- 2021
- Full Text
- View/download PDF
8. Is brivaracetam-induced elevation of carbamazepine-epoxide levels common and clinically relevant? - A case series.
- Author
-
Steinhoff BJ, Bacher M, Blickhan M, Bernedo V, Dietmann D, Intravooth T, Kornmeier R, Kurth C, Mahn P, Schneider M, Stockinger J, and Staack AM
- Subjects
- Adult, Carbamazepine blood, Epilepsies, Partial blood, Female, Humans, Male, Middle Aged, Seizures blood, Carbamazepine analogs & derivatives, Epilepsies, Partial drug therapy, Pyrrolidinones therapeutic use, Seizures drug therapy
- Abstract
Brivaracetam (BRV) was recently introduced for the treatment of patients with focal epilepsy. BRV undergoes relatively few interactions, but one of them leads to the elevation of carbamazepine (CBZ)-10,11-CBZ-epoxide (CBZ-E) if BRV is co-administered with CBZ. This interaction has been considered to be clinically negligible. We present a case series of nine patients. In eight of them, levetiracetam (LEV) was switched to BRV. In the remaining case, oxcarbazepine was replaced by CBZ and added to a stable BRV dose. A marked increase of CBZ-E occurred in every case and was associated with clinically relevant symptoms including blurred vision, diplopia, dizziness, or fatigue in three of them. However, in the remaining six, the elevated CBZ-E levels were not associated with any tolerability problems. The importance of CBZ-E for adverse events under CBZ may have been overemphasized in the past and is not clinically impairing in most cases treated with the combination of BRV and CBZ., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
9. Diagnóstico y tratamiento de la esofagitis eosinofílica en niños. Revisión de la literatura y recomendaciones basadas en la evidencia. Grupo de trabajo de la Sociedad Latinoamericana de Gastroenterología, Hepatología y Nutrición pediátrica (SLAGHNP).
- Author
-
Pierre R, Guisande A, Sifontes L, Sosa P, Ninomiya I, González L, Jaen D, Del Compare M, Vives LA, Navarro D, Rojo C, Días JA, Zablah R, Medina F, Calderón O, Iglesias C, Toca MC, Tanzi MN, Arancibia ME, León K, Bernedo V, Cohen J, Ussher F, Becker D, and Figuereo C
- Subjects
- Child, Eosinophilic Esophagitis etiology, Esophagoscopy, Evidence-Based Medicine, Humans, Societies, Medical, Eosinophilic Esophagitis diagnosis, Eosinophilic Esophagitis therapy, Gastroesophageal Reflux complications
- Abstract
During the last twenty years Eosinophilic Esophagitis has become one the most important causes of esophageal disfunction in children, food impactation in adolescents and young adults, therapeutic failure in patients with gastroesophageal reflux disease (GERD) and the most frecuent eosinophilic disease of the gastrointestinal tract. We present recommendations for the diagnosis and treatment of the disease based in a systematic review of the literature.
- Published
- 2015
10. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.
- Author
-
Werhahn KJ, Trinka E, Dobesberger J, Unterberger I, Baum P, Deckert-Schmitz M, Kniess T, Schmitz B, Bernedo V, Ruckes C, Ehrlich A, and Krämer G
- Subjects
- Aged, Dose-Response Relationship, Drug, Double-Blind Method, Europe, Female, Humans, Kaplan-Meier Estimate, Logistic Models, Longitudinal Studies, Male, Middle Aged, Retrospective Studies, Time Factors, Treatment Outcome, Anticonvulsants therapeutic use, Epilepsies, Partial drug therapy
- Abstract
Objective: To compare the effectiveness of controlled-released carbamazepine (CR-CBZ) to levetiracetam (LEV) and to lamotrigine (LTG) in elderly patients with newly diagnosed focal epilepsy., Methods: Randomized, double-blind, parallel-group trial conducted between January 2007 and August 2011, in 47 ambulatory or hospital sites in Germany, Austria, or Switzerland. Eligible participants were aged ≥ 60, had new-onset epilepsy, had no acute illness as the cause of their seizures, and had no contraindication to the drugs in the trial. Patients were randomized 1:1:1 to CR-CBZ, LTG, or LEV. Doses were up-titrated for 6 weeks and could be maintained or adjusted depending on seizure relapse or tolerability over an additional period of 52 weeks. Primary outcome was the retention to treatment at week 58; secondary measures related to seizure and adverse event frequency., Results: Of 361 randomized patients, 359 were included (CR-CBZ n = 121, LTG n = 117, LEV n = 122) in the modified intent-to-treat population (mean age [range] 71.4 [60-95] years). At week 58, the retention rate for LEV was significantly higher than for CR-CBZ (61.5% vs. 45.8%, p = 0.02), and similar to LTG (55.6%). Seizure freedom rates at weeks 30 and 58 were not different across the groups. Twice as many patients receiving CR-CBZ discontinued due to adverse events or death compared to those in the LEV group (32.2% vs. 17.2%; odds ratio 2.28, 95% confidence interval [CI] 1.25-4.19, p = 0.007), whereas discontinuation was intermediate for LTG (26.3%). Median daily doses of completers (n = 195) were CR-CBZ 380.0 mg/day (333.0-384.0), LTG 95 mg/day (94.0-97.0), and LEV 950 mg/day (940.0-985.0)., Significance: In the initial monotherapy of focal epilepsy in the elderly, 1-year retention to LEV was higher compared to CR-CBZ due to better tolerability. Retention of LTG was intermediate and close to LEV, but did not differ significantly from either comparators. NCT00438451, www.clinicaltrials.gov., (Wiley Periodicals, Inc. © 2015 International League Against Epilepsy.)
- Published
- 2015
- Full Text
- View/download PDF
11. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
- Author
-
Landvogt C, Buchholz HG, Bernedo V, Schreckenberger M, and Werhahn KJ
- Subjects
- Adolescent, Adult, Basal Ganglia diagnostic imaging, Basal Ganglia metabolism, Benzamides metabolism, Brain diagnostic imaging, Corpus Striatum diagnostic imaging, Corpus Striatum metabolism, Fluorine Radioisotopes metabolism, Functional Laterality, Humans, Male, Myoclonic Epilepsy, Juvenile diagnosis, Myoclonic Epilepsy, Juvenile diagnostic imaging, Positron-Emission Tomography statistics & numerical data, Putamen diagnostic imaging, Putamen metabolism, Pyrrolidines metabolism, Temporal Lobe diagnostic imaging, Temporal Lobe metabolism, Tissue Distribution, Brain metabolism, Dopamine metabolism, Myoclonic Epilepsy, Juvenile metabolism, Receptors, Dopamine D2 metabolism, Receptors, Dopamine D3 metabolism
- Abstract
Purpose: To quantify extrastriatal and striatal D2/D3 receptor binding in patients with juvenile myoclonic epilepsy (JME) using the high-affinity dopamine D2/D3 receptor positron emission tomography (PET) ligand (18) F-Fallypride ([(18) F]FP)., Methods: Twelve patients with JME and 21 age-matched control subjects were studied. Dynamic images (180 min) were acquired after injection of [(18) F]FP. Patients had been seizure-free of all seizure types for at least 10 days before scanning. Parametric images of binding potential (BP) were created using the simplified reference tissue model. The images were stereotactically normalized using a ligand-specific template. We performed a voxel-based analysis with statistical parametric mapping (SPM2). Region of interest (ROI) analysis was done comparing the BP of the thalamus, caudate nucleus, anterior (ventral) and posterior (dorsal) putamen, ventral striatum, and temporal lobe., Results: Compared to controls, patients with JME showed a significant decrease in [(18) F]FP BP (SPM analysis corr. p < 0.001 at cluster level) restricted to the bilateral posterior putamen. There was no significant alteration of [(18) F]FP binding in other brains regions. ROI analysis revealed a significant (p < 0.05) decrease of [(18) F]FP BP in the left (mean -14.8%) and right (mean -16.9%) posterior putamen, but not in the anterior putamen, caudate, ventral striatum, thalamus, or temporal lobe., Discussion: Patients with JME showed a reduction in D2/3 receptor binding restricted to the bilateral posterior putamen, suggesting a specific alteration of the dopaminergic system. Whether these changes can be regarded as merely functional or whether they relate to the pathophysiology of juvenile myoclonic epilepsy still remains unclear., (Wiley Periodicals, Inc. © 2010 International League Against Epilepsy.)
- Published
- 2010
- Full Text
- View/download PDF
12. Beta-amyloid cortical deposits are accompanied by the loss of serotonergic neurons in the dog.
- Author
-
Bernedo V, Insua D, Suárez ML, Santamarina G, Sarasa M, and Pesini P
- Subjects
- Alzheimer Disease pathology, Analysis of Variance, Animals, Cell Count, Dogs, Immunohistochemistry, Neurons physiology, Raphe Nuclei metabolism, Tryptophan Hydroxylase metabolism, Aging, Alzheimer Disease veterinary, Amyloid beta-Peptides metabolism, Dog Diseases pathology, Nerve Degeneration veterinary, Neurons pathology, Raphe Nuclei pathology, Serotonin metabolism
- Abstract
Dogs may naturally suffer an age-related cognitive impairment that has aroused a great deal of interest, even beyond the field of the veterinary clinic. This canine senile dementia reproduces several key aspects of Alzheimer's disease (AD), including the presence of beta-amyloid (A beta) deposits in the cerebral cortex, neurodegeneration, and learning and memory impairments. In the present study, we have used unbiased stereological procedures to estimate the number of the dorsal and median raphe nuclei (DRN and MRN, respectively) serotonergic neurons immunolabeled with an anti-tryptophan hydroxylase (TrH) monoclonal antibody in young and aged dogs without A beta cortical deposits and in aged dogs with A beta cortical deposits. The estimated total number of TrH-labeled neurons (mean +/- SD) was 94,790 +/- 26,341 for the DRN and 40,404 +/- 8,692 for the MRN. The statistical analyses revealed that aged dogs with A beta cortical pathology had 33% fewer serotonergic neurons in the DRN and MRN than aged dogs without A beta cortical deposits (108,043 +/- 18,800 vs. 162,242 +/- 39,942, respectively; P = 0.01). In contrast, no significant variations were found between young and aged dogs without A beta cortical deposits. These results suggest that degeneration of the serotonergic neurons could be involved in the cognitive damage that accompanies A beta cortical pathology in the dog and reinforce the use of the canine model for exploring the potential mechanisms linking the cortical A beta pathology and serotonergic neurodegeneration that occurs during the course of AD., ((c) 2009 Wiley-Liss, Inc.)
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.